Indeed, we previously showed that an increased ratio of active STAT1/STAT3 in breast tumors is associated with improved immune surveillance, increased production of inflammatory cytokines, and enhanced sensitivity to immune checkpoint inhibitors in breast cancer [86]. This evidence concerns the gene STAT3 and breast cancer.